SCRIVANICH LUKE M 4
4 · VIAVI SOLUTIONS INC. · Filed Sep 25, 2025
Insider Transaction Report
Form 4
SCRIVANICH LUKE M
SVP General Manager OSP
Transactions
- Exercise/Conversion
Common Stock
2025-09-23+12,317→ 82,078 total - Tax Payment
Common Stock
2025-09-23$12.41/sh−6,255$77,625→ 75,823 total - Exercise/Conversion
Common Stock
2025-09-23+25,396→ 101,219 total - Exercise/Conversion
Common Stock
2025-09-23+5,944→ 72,780 total - Exercise/Conversion
Market Stock Units
2025-09-23−25,396→ 39,682 totalExercise: $0.00→ Common Stock (25,396 underlying) - Tax Payment
Common Stock
2025-09-23$12.41/sh−3,019$37,466→ 69,761 total - Tax Payment
Common Stock
2025-09-23$12.41/sh−12,897$160,052→ 88,322 total - Exercise/Conversion
Market Stock Units
2025-09-23−5,944→ 0 totalExercise: $0.00→ Common Stock (5,944 underlying) - Exercise/Conversion
Market Stock Units
2025-09-23−12,317→ 13,637 totalExercise: $0.00→ Common Stock (12,317 underlying)
Footnotes (6)
- [F1]Each stock unit converts upon vesting into one share of common stock.
- [F2]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award or performance stock award, as applicable. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F3]Shares reflect the vesting of the 3rd tranche of market-leveraged stock units granted on August 28, 2022 at 56.67% of target based on our total stockholder return during the performance periods as stated on the grant agreement.
- [F4]There are no expiration dates on MSUs.
- [F5]Shares reflect the vesting of the 2nd tranche of market-leveraged stock units granted on August 28, 2023 at 90.33% of target based on our total stockholder return during the performance periods as stated on the grant agreement.
- [F6]Shares reflect the vesting of the 1st tranche of market-leveraged stock units granted on August 28, 2024 at 128.00% of target based on our total stockholder return during the performance periods as stated on the grant agreement.